Driehaus
@driehaus.com
Founded in 1982 by renowned investor Richard H. Driehaus, we are an independent, boutique investment adviser managing equity and multi-asset strategies.
Driehaus's Company Logos
Driehaus's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#91B3DA
Polo Blue
145, 179, 218
212, 50, 71
33, 18, 0, 15
#F3F3F3
Concrete
243, 243, 243
0, 0, 95
0, 0, 0, 5
#152236
Big Stone
21, 34, 54
216, 44, 15
61, 37, 0, 79
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
About Driehaus
Driehaus is an independent, boutique investment adviser that specializes in managing equity and multi-asset strategies. With a 35+ year heritage of serving professional investors, Driehaus offers a wide range of differentiated investment options. Their strategies include US Growth Equities, International Growth Equities, Emerging Markets, Global, and Alternative Investments.
These strategies are managed by experienced investment teams, who follow proven investment philosophies to deliver strong performance. Driehaus currently has $14. 9 billion in assets under management as of 7/31/23, and their performance has been a key focus for them.
They align their interests with those of their clients, ensuring that their investment professionals are dedicated to delivering results. But it's not just about the numbers - Driehaus values its people. They believe that their smart, passionate, and intellectually curious employees are their greatest asset.
The company fosters a culture of community, corporate social responsibility, and employee engagement. With a robust business infrastructure and a Chicago-based firm, Driehaus combines institutional support and service with a boutique investment environment. Founded by Richard H.
Driehaus in 1982, the company continues to uphold his vision and principles. For more information about Driehaus and their investment offerings, visit their website or get in touch with their Chicago-based team
Related Brands
Tags
Active equity management
Micro cap and small cap growth
Emerging markets equities
International developed equities
Life sciences investing
